Tuesday, May 17, 2022
HomeBreaking NewsGenetic Technologies Limited (GENE) CEO Simon Morriss on Q3 2022 Results -...

Genetic Technologies Limited (GENE) CEO Simon Morriss on Q3 2022 Results – Earnings Call Transcript

Genetic Technologies Limited (NASDAQ: GENE ) Q3 2022 Earnings Conference Call April 20, 2022 6:00 PM ET Company Participants Simon Morriss – Chief Executive Officer Mike Tonroe – Chief Financial Officer Dr. George Muchnik – Non-Executive Director and Medical Advisor Conference Call Participants MichaelTonroe Hello and welcome to our Quarter Three business update. I’m Mike Tonroe, Chief Financial Officer Genetic Technologies. I’m also your house and moderator. Thank you for taking the time to join us today. There will be a presentation with a focus on our quarter three results ending 31st of March 2022, and our plans for […]

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -
Google search engine

Most Popular

Recent Comments